Perceptive Advisors LLC Aquestive Therapeutics, Inc. Transaction History
Perceptive Advisors LLC
- $44.8 Billion
- Q3 2025
A detailed history of Perceptive Advisors LLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 3,760,099 shares of AQST stock, worth $20.3 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
3,760,099
Previous 2,190,420
71.66%
Holding current value
$20.3 Million
Previous $7.25 Million
189.9%
% of portfolio
0.05%
Previous 0.32%
Shares
8 transactions
Others Institutions Holding AQST
# of Institutions
163Shares Held
65.9MCall Options Held
794KPut Options Held
457K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$52.9 Million100.0% of portfolio
-
Rtw Investments, LP New York, NY6.25MShares$33.7 Million0.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.66MShares$30.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$29.4 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2.63MShares$14.1 Million1.1% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $288M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...